Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Patients With Mild Cognitive Impairment
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The beneficial effect of nocturnal as well as daytime sleep on memory consolidation is well-documented in young, healthy subjects. Slow wave sleep (SWS), in particular, with its slow oscillating activity have shown to enhance declarative, hippocampus-dependent memory representations. This impact of sleep on memory performance can be additionally enhanced by exogeneous induction of transcranial slow oscillating stimulation (tSOS) within the frequency range of SWS in humans (0,7- 0,8 Hz) during sleep, as has been demonstrated in young, healthy subjects. If patients with amnestic mild cognitive impairment (MCI)- usually characterized by initial difficulties in hippocampus dependent memory functions - benefit from transcranial slow oscillatory stimulation (tSOS) during sleep as well has not been studied so far. The primary goal of the study is therefore to investigate the impact of oscillating current stimulation (tSOS) during a daytime nap on declarative memory consolidation in MCI patients.
| Condition | Intervention |
|---|---|
|
Mild Cognitive Impairment, So Stated |
Device: SHAM stimulation Device: 0,75 Hz stimulation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Treatment |
| Official Title: | Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Slow Wave Sleep of a Daytime Nap in Patients With Mild Cognitive Impairment(MCI) |
- Retention of declarative memories after 0.75 Hz stimulation during SWS, vs after sham stimulation during SWS [ Time Frame: 4 Weeks ] [ Designated as safety issue: No ]Retention between stimulation conditions (0.75 Hz during SWS, vs sham stimulation during SWS) in the declarative memory task.
- Amount of Slow wave Sleep, spindels, eeg-correlates, further memory systems [ Time Frame: 4 Weeks ] [ Designated as safety issue: No ]
- Amount of slow wave sleep assessed by standard polysomnographic criteria in 0,75 Hz vs SHAM stimulation during SWS.
- Spindel activity during sleep indicated via several spindel parameters like number, duration, frequency of spindles; compared between 0,75 Hz and SHAM stimulation during SWS.
- Neuronal correlates (EEG-power in slow oscillation frequency bands induced by 0,75 Hz vs SHAM stimulation during SWS; EEG-correlates of encoding and retrieval of a declarative memory task).
- Performance in further memory systems (procedural), compared between 0,75 Hz and SHAM stimulation during SWS.
| Estimated Enrollment: | 22 |
| Study Start Date: | April 2013 |
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | March 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 0,75 Hz stimulation
transcranial slow oscilliating stimulation (tSOS)during periods of SWS
|
Device: 0,75 Hz stimulation
Other Name: oscillating direct current brain stimulation
|
|
Sham Comparator: SHAM stimulation
SHAM stimulation during periods of SWS
|
Device: SHAM stimulation
no stimulation
|
Eligibility| Ages Eligible for Study: | 50 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
amnestic and amnestic plus MCI-patients:
- Concern reflecting a change in cognition reported by patient or informant or clinician (i.e., historical or observed evidence of decline over time)
- Objective evidence of memory impairment; additional cognitive domains may be affected as well;
- Preservation of independence in functional abilities
- no dementia
- age: 50-80 years
Exclusion Criteria:
- untreated severe internal or psychiatric diseases
- epilepsy
- other severe neurological diseases eg., previous major stroke, brain tumour
- dementia
- contraindications to MRI
Contacts and Locations| Contact: Julia Schneider, M. sc. | 030/450 560 136 | schneider.julia@charite.de |
| Contact: Nadine Külzow, Dr | 030/ 450 560 140 | nadine.külzow@charite.de |
| Germany | |
| Charite CCM Neurologie Berlin | Recruiting |
| Berlin, Germany, 10117 | |
| Contact: Julia Schneider, M.sc. + 49/ 30/ 450 560 136 schneider.julia@charite.de | |
| Contact: Agnes Flöel, Prof. Dr. +49/ 30/ 450 560 284 agnes.floeel@charite.de | |
| Sub-Investigator: Nadine Külzow, Dr. | |
| Sub-Investigator: Julia Schneider, M.sc. | |
| Principal Investigator: Agnes Flöel, Prof. Dr. | |
| Study Chair: | Agnes Flöel, Professor | Charite Universitätsmedizin Berlin - Neurologie |
More Information
Additional Information:
Publications:
| Responsible Party: | Agnes Floeel, Prof. Agnes Flöel, MD, Charite University, Berlin, Germany |
| ClinicalTrials.gov Identifier: | NCT01782365 History of Changes |
| Other Study ID Numbers: | Nap-tSOS-MCI |
| Study First Received: | January 31, 2013 |
| Last Updated: | April 18, 2013 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by Charite University, Berlin, Germany:
|
mild cognitive impairment dementia MCI brain stimulation tSOS tDCS |
sleep nap daytime sleep memory memory consolidation |
Additional relevant MeSH terms:
|
Cognition Disorders Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013